Literature DB >> 18953246

Long-term survival after pancreatoduodenectomy for ductal adenocarcinoma: the emperor has no clothes?

Edward L Bradley.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18953246     DOI： 10.1097/MPA.0b013e31818e9100

Source DB:  PubMed          Journal:  Pancreas        ISSN： 0885-3177            Impact factor:   3.327


× No keyword cloud information.
  16 in total

1.  An Evaluation of Artificial Neural Networks in Predicting Pancreatic Cancer Survival.

Authors:  Steven Walczak; Vic Velanovich
Journal:  J Gastrointest Surg       Date:  2017-08-03       Impact factor: 3.452

2.  Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer.

Authors:  Sohei Satoi; Hideyoshi Toyokawa; Hiroaki Yanagimoto; Tomohisa Yamamoto; Minoru Kamata; Chisato Ohe; Noriko Sakaida; Yoshiko Uemura; Hiroaki Kitade; Noboru Tanigawa; Kentaro Inoue; Yoichi Matsui; A-Hon Kwon
Journal:  J Gastrointest Surg       Date:  2011-12-09       Impact factor: 3.452

3.  Redefining mortality after pancreatic cancer resection.

Authors:  James Edward Carroll; Jillian K Smith; Jessica P Simons; Melissa M Murphy; Sing Chau Ng; Shimul A Shah; Zheng Zhou; Jennifer F Tseng
Journal:  J Gastrointest Surg       Date:  2010-09-16       Impact factor: 3.452

Review 4.  Early enteral nutrition after pancreatoduodenectomy: a meta-analysis of randomized controlled trials.

Authors:  Yinfeng Shen; WenYin Jin
Journal:  Langenbecks Arch Surg       Date:  2013-05-22       Impact factor: 3.445

Review 5.  Neoadjuvant therapy in pancreatic adenocarcinoma: a meta-analysis of phase II trials.

Authors:  M Mura Assifi; Xuyang Lu; Guido Eibl; Howard A Reber; Gang Li; O Joe Hines
Journal:  Surgery       Date:  2011-09       Impact factor: 3.982

6.  Stromal galectin-1 expression is associated with long-term survival in resectable pancreatic ductal adenocarcinoma.

Authors:  Ru Chen; Sheng Pan; Niki A Ottenhof; Roeland F de Wilde; Christopher L Wolfgang; Zhaoli Lane; Jane Post; Mary P Bronner; Jürgen K Willmann; Anirban Maitra; Teresa A Brentnall
Journal:  Cancer Biol Ther       Date:  2012-08-01       Impact factor: 4.742

7.  Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer.

Authors:  Keinosuke Ishido; Yoshikazu Toyoki; Daisuke Kudo; Norihisa Kimura; Daisuke Yamana; Takuya Miura; Shinji Tsutsumi; Takahiro Muroya; Toru Yoshikawa; Hiroshi Ogasawara; Shinnosuke Yonaiyama; Shunji Narumi; Kenichi Hakamada
Journal:  Oncol Lett       Date:  2011-09-05       Impact factor: 2.967

8.  Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic ductal adenocarcinoma.

Authors:  Harish Lavu; Andres A Mascaro; Dane R Grenda; Patricia K Sauter; Benjamin E Leiby; Sean P Croker; Agnes Witkiewicz; Adam C Berger; Ernest L Rosato; Eugene P Kennedy; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

9.  Role of radical antegrade modular pancreatosplenectomy for adenocarcinoma of the body and tail of the pancreas.

Authors:  Hyo Jun Park; Dong Do You; Dong Wook Choi; Jin Seok Heo; Seong Ho Choi
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

10.  The impact of simultaneous liver resection for occult liver metastases of pancreatic adenocarcinoma.

Authors:  F Klein; G Puhl; O Guckelberger; U Pelzer; J R Pullankavumkal; S Guel; P Neuhaus; M Bahra
Journal:  Gastroenterol Res Pract       Date:  2012-11-08       Impact factor: 2.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.